Effect of Evogliptin on Bone Metabolism in Human

Inclusion Criteria: * Postmenopausal healthy women (at least 5 years) * BMI 18\~30 kg/m2 Exclusion Criteria: * Presence or history of hypersensitivity or allergic reactions to any drug * Clinically relevant abnormal medical history or present disease * Presence or history of drug abuse * Participation in other clinical trial within 2 months before dose. * Bood donation during 2 months or apheresis during 1 month before the study. * Use of a prescription medicine, herbal medicine within 2 weeks or over-the-counter medication or vitamin substances within 1 week before dose. * Use of any drug which can affect bone metabolism such as sex hormones or their receptor related medicine, calcitonin or parathyroid hormone related medicine, systemic corticosteroid, bisphosphate, or etc. * Smoking of more than 10 cigarettes/days within 3 months before first dose. * Use of alcohol over 21 units/weeks * Subject judged not eligible for study participation by investigator.